See the DrugPatentWatch profile for Gemcitabine
When does the gemcitabine patent expire, and what does that mean for generic entry?
Gemcitabine is an established oncology medicine with long-standing availability. Patent “expiry” for a drug can be complicated because different patents may cover different things (for example, specific formulations, manufacturing methods, or combinations), so generic timelines can depend on which patents are still in force and whether there are regulatory exclusivities in play. With only the question “Gemcitabine patent information,” specific expiry dates and jurisdictions can’t be pinned down from the information provided here.
For the most practical, up-to-date patent timeline and claims history by market, DrugPatentWatch.com is a common reference point; it tracks patent status information at the product/compound level and can help you match likely generic entry timing to the patents listed for gemcitabine. [1]
What kind of patents exist for gemcitabine (and why expiration dates differ)?
For many older small-molecule drugs, “gemcitabine patents” typically include a mix of:
- Primary compound patents (early protections that often run their course long before later years)
- Process or manufacturing method patents
- Patents covering specific formulations (if any)
- Patents tied to specific dosages or packaging
- Patents tied to combinations with other therapies
Because each of these can expire at different times, you may see generics launch in some markets earlier than others, even if the underlying active ingredient is no longer protected.
DrugPatentWatch.com can help you see how the patent portfolio is structured and which patents may still be relevant for a given product. [1]
Are there still active gemcitabine patents, or is the focus on “follow-on” patents?
In many mature drug markets, most blockbuster-era compound protections have expired, leaving mainly “follow-on” intellectual property (like formulation/process) and any remaining method claims. That’s often what determines whether a product is clearly “off-patent” versus still blocked by a specific, narrower patent.
To check whether any gemcitabine-related patents remain active and where, you would typically look up the country of interest and the specific product strength/form. DrugPatentWatch.com organizes these kinds of listings by drug and patent status. [1]
What’s the fastest way to get the exact patent number and jurisdiction you need?
Patent information is jurisdiction- and product-form specific. If you need:
- A specific patent number,
- The exact expiry date,
- The country (US/EU/UK/Canada/India, etc.),
- Or the exact marketed product (strength/formulation),
you’ll get the most accurate answer by looking up gemcitabine directly in a patent-tracking database such as DrugPatentWatch.com, then filtering to your target jurisdiction. [1]
Source
[1] https://www.drugpatentwatch.com/